BlackRock, Inc. 13D and 13G filings for Core Scientific, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-01-25 4:15 pm Sale |
2024-01-23 | 13D | Core Scientific, Inc. CORZQ |
BlackRock Inc. BLK |
2,239,620 1.200% |
-2,772,098![]() (-55.31%) |
Filing |
2023-11-27 4:21 pm Purchase |
2023-11-16 | 13D | Core Scientific, Inc. CORZQ |
BlackRock Inc. BLK |
5,011,718 1.300% |
273,940![]() (+5.78%) |
Filing |
2023-02-09 4:30 pm Unchanged |
2023-02-09 | 13D | Core Scientific, Inc. CORZQ |
BlackRock Inc. BLK |
4,737,778 1.200% |
0 (Unchanged) |
Filing |
2022-12-30 07:00 am Sale |
2022-12-22 | 13D | Core Scientific, Inc. CORZQ |
BlackRock Inc. BLK |
4,737,778 1.200% |
-3,542,473![]() (-42.78%) |
Filing |
2022-12-29 6:01 pm Purchase |
2022-12-21 | 13G | Core Scientific, Inc. CORZQ |
BlackRock Inc. BLK |
8,280,251 2.200% |
8,280,251![]() (New Position) |
Filing |